期刊文献+

经左颈胸二切口术与经右颈胸腹三切口术治疗食管癌的疗效比较 被引量:1

The curative effect comparison between 2-incisions through left thoracic-cervical pathway and 3-incision through rignt thoracic-cervical pathway in the treatment of esophageal cancer
原文传递
导出
摘要 目的比较经左颈胸二切口术与经右颈胸腹三切口术治疗食管癌的疗效。方法选择2009年10月至2013年10月间收治的46例食管癌患者作为观察组,选取同期收治的52例食管癌患者作为对照组,观察组给予经左颈胸二切口术治疗,对照组给予经右颈胸腹三切口术治疗,对比分析两组患者治疗后手术并发症发生率、手术期病死率、1年生存率、3年生存率和5年生存率以及生活质量。结果观察组并发症发生率和围手术期死亡率分别为15.2%和2.2%,明显低于对照组的36.5%和15.4%,差异有统计学意义(P<0.05)。观察组患者1年生存率、3年生存率与对照组比较,差异无统计学意义(P>0.05);5年生存率明显高于对照组(P<0.05)。观察组患者进餐后胸闷不适感和体重下降发生率明显低于对照组,差异有统计学意义(P<0.05)。两组患者食欲不振、吞咽困难、腹泻、反酸发生率比较,差异无统计学意义(P>0.05)。结论与经右颈胸腹三切口术比较,经左颈胸二切口术治疗食管癌能有效降低患者手术并发症发生率、围手术期死亡率、进餐后胸闷不适感、体重下降发生率,提高5年生存率,效果较为理想,具有很好的临床应用推广价值。 Objective To find better surgical method by comparing the therapeutic efficacy of 2-incisions through left thoracic-cervical pathway and 3-incision through rignt thoracic-cervical pathway in the treatment of esophageal cancer.Methods Forty-six cases of esophageal cancer patients from October 2009 to October 2013 treated in the hospital were collected as the observation group,and other 52 patients in control group who came from the same period in the hospital.Patients of the observation group received 2-incisions through left thoracic-cervical pathway,patients in the control group operated through rignt thoracic-cervical pathway 3-incision.The operative mortality,1-year,3-year and 5-year survival rate of survival and quality of life in two groups were comparated and analysed after treatment.Results The rate of complications and preoperative mortality in observation group were 15.2% and 2.2%,significantly lower than the control group(36.5% and 15.4%),the differences were statistically significant(P 〈 0.05).1-year survival rate,3-year survival rate of observation group compared with the control group,there were no statistically significant differences(P 〉 0.05);The 5-year survival rate was significantly higher than the control group(P 〈 0.05).Chest discomfort after eating and weight loss rate in observation group were significantly lower than the control group,the difference was statistically significant(P 〈 0.05);loss of appetite between the two groups(P 〉 0.05).Conclusions Comparing with 3-incision through right thoracic-cervical pathway,2-incision esophagectomy via left thoracic-cervical pathway in treatment of esophageal cancer can effectively reduce the incidence of complications,perioperative mortality,5-year survival rate,incidence of chest discomfort after eating,weight loss in patients with esophagus carcinoma.It has great value in clinical application promotion.
出处 《中国肿瘤临床与康复》 2014年第11期1356-1358,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 经左颈胸二切口术 经右颈胸腹三切口术 食管肿瘤 并发症 2-incisions through left thoracic-cervical pathway 3-incision through rignt thoraciccervical pathway Esophageal neoplasms Complications
  • 相关文献

参考文献11

  • 1Ayyappan S, Prabhakar D, Sharma N. Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer [J]. Anticancer Res, 2013, 33:4139-4155. 被引量:1
  • 2Bao Y, Liu S,Zhou Q,et al. Three-dimensional conformal radio- therapy with concurrent chemotherapy for postoperative recur- rence of esophageal squamous cell carcinoma: Clinical efficacy and failure pattern[J]. Radiat Oncol, 2013, 8:241. 被引量:1
  • 3Bekkar S, Gronnier C, Messager M,et al. The impact of preoper- ative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma[ J]. Ann Thorac Surg, 2014, 97:303-310. 被引量:1
  • 4Ben-David K, Behrns K, Hochwald S, et al. Esophageal perfora- tion management using a multidisciplinary minimally invasive treatment algorithm[ J]. J Am Coil Surg, 2014, 218:768-774. 被引量:1
  • 5Boland PM, Burtness B. Esophageal carcinoma: Are modern tar- geted therapies shaking the rock? [J]. Curr Opin Oncol, 2013, 25:417-424. 被引量:1
  • 6Fu C,Li B,Guo L,et al. Phase Ⅱ study of concurrent selective lymph node late course accelerated hyper-fractionated radiothera- py and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma [ J ] . Br J Radiol, 2014, 87:20130656. 被引量:1
  • 7Li B ,Tsao SW, Chan KW, et al. Idl-induced IGF2 and its auto- crine/endocrine promotion of esophageal cancer progression and chemoresistance - Implications for IGF2 and IGF1R-targeted therapy[ J]. Clin Cancer Res, 2014, 20:2651-2662. 被引量:1
  • 8Liang J, E M, Wu G, et al. Nimotuzumab combined with radio- therapy for esophageal cancer: preliminary study of a phase Ⅱ clinical trial[ J ]. Oncol Targets Ther, 2013, 6 : 1589-1596. 被引量:1
  • 9Liu YE, Lin Q, Meng FJ, et al. High-dose accelerated hypofrac- tionated three-dimensional cmfformal radiotherapy ( at 3 Gy/frac- tion) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: A feasibility study[ J]. Radiat Oncol, 2013, 8:198. 被引量:1
  • 10Min BH,Kim ER,Lee JH,et al. Feasibility and efficacy of ar- gon plasma coagulation for early esophageal squamous cell neo- plasia[J]. Endoscopy, 2013, 45:575-578. 被引量:1

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部